PAHC vs. CALT, KRRO, OLMA, ALT, MLYS, PHAT, ATXS, AVBP, VERV, and STOK
Should you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Calliditas Therapeutics AB (publ) (CALT), Korro Bio (KRRO), Olema Pharmaceuticals (OLMA), Altimmune (ALT), Mineralys Therapeutics (MLYS), Phathom Pharmaceuticals (PHAT), Astria Therapeutics (ATXS), ArriVent BioPharma (AVBP), Verve Therapeutics (VERV), and Stoke Therapeutics (STOK). These companies are all part of the "pharmaceutical preparations" industry.
Phibro Animal Health (NASDAQ:PAHC) and Calliditas Therapeutics AB (publ) (NASDAQ:CALT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk.
Phibro Animal Health has higher revenue and earnings than Calliditas Therapeutics AB (publ). Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.
Phibro Animal Health currently has a consensus price target of $15.33, indicating a potential upside of 20.45%. Calliditas Therapeutics AB (publ) has a consensus price target of $34.00, indicating a potential upside of 74.35%. Given Calliditas Therapeutics AB (publ)'s stronger consensus rating and higher probable upside, analysts clearly believe Calliditas Therapeutics AB (publ) is more favorable than Phibro Animal Health.
Phibro Animal Health has a net margin of 1.51% compared to Calliditas Therapeutics AB (publ)'s net margin of -38.72%. Phibro Animal Health's return on equity of 16.67% beat Calliditas Therapeutics AB (publ)'s return on equity.
Phibro Animal Health received 279 more outperform votes than Calliditas Therapeutics AB (publ) when rated by MarketBeat users. However, 60.47% of users gave Calliditas Therapeutics AB (publ) an outperform vote while only 60.04% of users gave Phibro Animal Health an outperform vote.
In the previous week, Phibro Animal Health had 3 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 8 mentions for Phibro Animal Health and 5 mentions for Calliditas Therapeutics AB (publ). Phibro Animal Health's average media sentiment score of 0.83 beat Calliditas Therapeutics AB (publ)'s score of 0.27 indicating that Phibro Animal Health is being referred to more favorably in the media.
Phibro Animal Health has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Comparatively, Calliditas Therapeutics AB (publ) has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.
99.3% of Phibro Animal Health shares are owned by institutional investors. Comparatively, 2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. 50.1% of Phibro Animal Health shares are owned by insiders. Comparatively, 2.2% of Calliditas Therapeutics AB (publ) shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Phibro Animal Health beats Calliditas Therapeutics AB (publ) on 12 of the 17 factors compared between the two stocks.
Get Phibro Animal Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PAHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Phibro Animal Health Competitors List
Related Companies and Tools
